Navigation Links
Roadmap to 25 percent reduction in premature deaths From RHD in the under 25s by 2025 published
Date:4/8/2013

The World Heart Federation has published a new position statement outlining the five key strategic targets required to meet its strategic goal for rheumatic heart disease (RHD) a 25% reduction in premature deaths from rheumatic fever (RF) and RHD among individuals aged <25 years by the year 2025.

RHD remains the most common cardiovascular disease in young people aged <25 years. RF and RHD have been almost eradicated in areas with establish economies. But RF and RHD are endemic in developing countries and are also common in poorer populations in middle-income countries (e.g. Brazil, India), as well as some indigenous populations in wealthy countries (Australia, New Zealand). Moreover, migration from low-income to high-income settings might be responsible for a new burden of RHD in high-income countries where the disease has been largely eliminated.

Conservative estimates indicate that there are between 15.6 and 19.6 million existing cases of RHD and its been estimated that there are around 252,000 new cases each year. Moreover, an estimated 233,000 to 468,164 individuals die from RHD each year, and hundreds of thousands of people are disabled by this disease and its long-term complications.

"RF and RHD are neglected diseases that require immediate attention," Professor Bongani Mayosi, Groote Schuur Hospital and University of Cape Town, South Africa; and Chair of the World Heart Federation Working Group on Rheumatic Fever and Rheumatic Heart Disease. "This position paper will form the platform for a detailed operational plan to address the barriers to RF and RHD control. The operational plan will be founded on science, research and quantifiable progress indicators to impact positively on millions of individuals with RHD."

A number of barriers have been identified that are currently preventing the control of RF and RHD.

  • Neglect of RF and RHD there is a relative lack of engagement in disease control by governments, civil society, patient advocates and funding agencies.
  • Scarcity of data and scientific knowledge Contemporary data is scarce. The current global figure for RHD mortality is speculative and likely to be a gross underestimate. But, descriptive and prognostic epidemiological data outlining disease prevalence, mortality and morbidity are critical for developing realistic targets and key performance indicators towards disease control.
  • Research Global research priorities for RF and RHD have been identified but there is a great need for resource allocation to conduct robust research into these priorities.
  • Vaccines a GAS vaccine is required for effective population-level primary prevention of RF is needed. GAS vaccine development and human testing has been underway for nearly a century with fluctuating enthusiasm. Few pharmaceutical companies have active internal programmes.
  • Access to health care Barriers exist to optimal primary, secondary and tertiary (medical and surgical care). Many patients around the world do not have access to the treatments they need at all stages of management.

The primary aim of this position paper is to serve as a guide on how to achieve the objective of controlling RHD and eliminating RF. Five strategic targets have been identified:

  1. Comprehensive register-based control programmes
  2. Global access to benzathine penicillin G
  3. Identification and development of public figures as 'RHD champions'
  4. Expansion of RHD training hubs
  5. Support for vaccine development

Moreover, this document is intended to provide the foundation for governments, civil society, patient advocates, clinicians, researchers and funding agencies to develop partnerships and unify global efforts to control RF and RHD.


'/>"/>

Contact: Charanjit Jagait
charanjit.jagait@worldheart.org
41-228-070-334
World Heart Federation
Source:Eurekalert

Related medicine news :

1. Study provides roadmap for delirium risks, prevention, treatment, prognosis and research
2. Alzheimers experts from Penn Summit provide strategic roadmap to tackle the disease
3. New roadmap suggests proven routes to ending health disparities
4. Ready for debut: Fruit-juice-infused chocolate with 50 percent less fat
5. Nearly 30 Percent of Americans Have High Blood Pressure: CDC
6. CodingCertification.Org in the Top 5 Percent in LinkedIn Most Viewed Profiles in 2012
7. Common gene variants explain 42 percent of antidepressant response
8. Port Washington, NY Dentist Dr. Doron Keren of Gold Coast Family Dental Receives 98 Percent Satisfaction Rating from Patient Reviews
9. Newly incarcerated have 1 percent acute hepatitis C prevalence
10. Sports and recreation injuries drop 12 percent for children ages 5-14 during past decade
11. Telestroke program increases access to stroke care by 40 percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... York, New York (PRWEB) , ... April 28, ... ... high-quality anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin ... cream provides the hydrating benefits of a moisturizer with the power of an ...
(Date:4/28/2017)... MEMPHIS, Tenn. (PRWEB) , ... April 28, 2017 , ... ... VeinViewer® system, today announced an alliance with B. Braun Medical Inc. , a ... central role in patient care with as many as 90 percent of hospital patients ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, ... the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to ... , Countless deodorants flood the aisles that contain harmful chemicals that should be ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: